NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA).
SIGN THE PETITION

Larissa Nitschke

Staff Editor & Staff Writer

Houston, Texas, USA

Larissa Nitschke is a PhD candidate in the Integrative Molecular and Biomedical Sciences Program at Baylor College of Medicine (BCM) in Houston, Texas. She earned her Bachelor’s degree in Biology from the Heinrich-Heine-University Düsseldorf, Germany. In 2015, she joined the laboratory of Dr. Huda Zoghbi at BCM. Her research focuses on the understanding the post-transcriptional and post-translational regulation of ATXN1, the causative gene for Spinocerebellar Ataxia Type 1 (SCA1).